Update: Equity markets remain weak as the S&P has a close look at its 9 day moving average support. For now, it holds but the ABCD pattern which gave nic esell signal on April 16 remains in place. RSI remains elevated and the MACD is closing and may flash up a sell signal crossover.
The S&P and Dow remain in the green while the Nasdaq is down 0.3%.
Sectors: Industrials and Energy are both +0.7% while Tech +0.2% and Consumer +0.2% are the weakest.
Selected Stocks: TSLA -1.3%, FB -1.6%, GME -1%, COIN -3%, PLTR +3%, NFLX -85, Peleton -35, Carnival and Royal Carribean +3%, Citrix +4%.
Here is what you need to know on Wednesday, April 21:
Equity markets suffered a little wobble on Tuesday as most indices closed in the red. Inflation was cited as one concern, but in fact traders were just looking to justify the fear sell-off after record highs. Inflation will be a long-term problem as you just cannot keep printing money with no consequence, economics 101. However, in the short term, 10-year yields remain subdued at 1.57%.
Netflix then dropped another bombshell after the close, falling as much as 10%. Again here the market looked for the appropriate excuse to justify what it wanted to do – sell off. NFLX smashed EPS and revenue expectations. It raised Q2 guidance above analyst estimates, but subscriber numbers missed. A $5 billion buyback also seems an odd choice as Netflix could surely better invest the cash in its own business.
The post-financial crisis simplicity of either risk-on or off is still in play. The dollar, gold and the Vix rally, while equities, and in particular emerging markets and Asia, dump. The KOSPI and Nikkei dropped nearly 2% overnight.
Oil drops 2% to $61.26, Bitcoin shrinks to sub $55,000 and the EUR/USD sets itself up for a break of 1.20.
Stay up to speed with hot stocks' news!
S&P 500 (SPX), Nasdaq (QQQ) top news
Russia President Putin warns against crossing Russia's red lines.
UK inflation picks up as March CPI rises +0.7%.
The US reaches 200 million covid vaccines administered.
Netflix (NFLX) beats earnings but misses on subscriber numbers. Announces buyback. see more.
Apple (AAPL) launches new products in a virtual unveiling.
SPAC deals dry up. 109 SPACs in March, just 10 in April-CNBC.
JNJ is to resume the EU rollout of its covid vaccine as EMA says ok to go ahead.
Verizon (VZ) beat EPS results and also beat on revenue but lost subscribers. Shares down in pre-market.
Haliburton (HAL) beats on earnings, shares up in pre-market.
Baker Hughes (BKR) earnings beat forecast, shares down in premarket.
Nasdaq (NDAQ) results beat forecasts, 10% dividend increase.
Moderna (MRNA) strikes a new covid vaccine supply deal with Israel.
AZN: Israel does not want AZN's covid vaccine and asks to send it elsewhere.
BHP says annual iron ore production to be at the upper end of forecasts.
Coinbase (COIN) Deutsche Boerse says it will delist COIN shares as missing reference data from an incorrect ticker LEI code.
Pfizer (PFE): Brazil in talks to buy 100 million covid vaccine doses.
Tesla (TSLA) registrations in California drop for Model 3 by 54% YoY, according to Cross-Sell.
Ups and downs
Netflix (NFLX): UBS, Evercore, Cowen & Co, Morgan Stanley and Piper Sandler cut price target. Wedbush and Stifel raise price target.
IBM: Credit Suisse, BMO and Morgan Stanley raise price target.
Apple (AAPL): Morgan Stanley raises price target. Goldman Sachs reiterates Sell rating.
Coinbase (COIN): Rosenblatt initiates coverage with a Buy rating, $450 price target.
Norwegian Cruise (NCLH): Goldman Sachs upgrades to Buy.
United Airlines (UAL): Deutsche Bank says a catalyst buy idea.
Economic releases
-637546070875394353.png)
The author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author is short SPY. The author has not received compensation for writing this article, other than from FXStreet.
This article is for information purposes only. The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice. It is important to perform your own research before making any investment and take independent advice from a registered investment advisor.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to accuracy, completeness, or the suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. The author will not be held responsible for information that is found at the end of links posted on this page.
Errors and omissions excepted.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD remained bid above 0.6500
AUD/USD extended further its bullish performance, advancing for the fourth session in a row on Thursday, although a sustainable breakout of the key 200-day SMA at 0.6526 still remain elusive.
EUR/USD faces a minor resistance near at 1.0750
EUR/USD quickly left behind Wednesday’s small downtick and resumed its uptrend north of 1.0700 the figure, always on the back of the persistent sell-off in the US Dollar ahead of key PCE data on Friday.
Gold holds around $2,330 after dismal US data
Gold fell below $2,320 in the early American session as US yields shot higher after the data showed a significant increase in the US GDP price deflator in Q1. With safe-haven flows dominating the markets, however, XAU/USD reversed its direction and rose above $2,340.
Bitcoin price continues to get rejected from $65K resistance as SEC delays decision on spot BTC ETF options
Bitcoin (BTC) price has markets in disarray, provoking a broader market crash as it slumped to the $62,000 range on Thursday. Meanwhile, reverberations from spot BTC exchange-traded funds (ETFs) continue to influence the market.
US economy: slower growth with stronger inflation
The dollar strengthened, and stocks fell after statistical data from the US. The focus was on the preliminary estimate of GDP for the first quarter. Annualised quarterly growth came in at just 1.6%, down from the 2.5% and 3.4% previously forecast.